| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | SELL | SELL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 3.34▲ | 3.32▲ | 3.37▼ | 3.50▼ | 3.73▼ |
| MA10 | 3.33▲ | 3.37▼ | 3.47▼ | 3.63▼ | 3.88▼ |
| MA20 | 3.32▲ | 3.48▼ | 3.51▼ | 3.84▼ | 3.84▼ |
| MA50 | 3.36▼ | 3.53▼ | 3.59▼ | 3.93▼ | 4.26▼ |
| MA100 | 3.47▼ | 3.60▼ | 3.79▼ | 3.78▼ | 4.72▼ |
| MA200 | 3.51▼ | 3.80▼ | 3.91▼ | 4.07▼ | 4.66▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.007▲ | -0.018▼ | -0.021▼ | -0.058▼ | -0.024▼ |
| RSI | 51.289▲ | 32.397▼ | 29.992▼ | 30.952▼ | 42.298▼ |
| STOCH | 61.190 | 20.963 | 22.719 | 5.953▼ | 27.655 |
| WILL %R | -30.000 | -75.000 | -75.000 | -91.855▼ | -93.050▼ |
| CCI | 81.690 | -59.918 | -119.897▼ | -130.065▼ | -249.056▼ |
|
Thursday, September 17, 2026 05:30 AM
CFO Chris Prentiss outlined the company’s commercial and development priorities at the H.C. Wainwright Global Investment Conference, emphasizing execution following three major 2026 catalysts: ...
|
|
Tuesday, September 15, 2026 07:58 PM
On 9, MannKind Corporation (NASDAQ:MNKD) announced a licensing and collaboration agreement with Rose Pharma Inc. to develop ROSE-010 Technosphere, an inhaled, rapid-acting glucagon-like peptide-1 ...
|
|
Tuesday, September 15, 2026 07:58 PM
On 9, MannKind Corporation (NASDAQ:MNKD) announced a licensing and collaboration agreement with Rose Pharma Inc. to develop ROSE-010 Technosphere, an inhaled, rapid-acting glucagon-like peptide-1 ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 22/09/26 | 3.53 | 3.53 | 3.255 | 3.345 | 11,310,035 |
| 21/09/26 | 3.55 | 3.62 | 3.47 | 3.50 | 4,524,398 |
| 18/09/26 | 3.59 | 3.6207 | 3.50 | 3.54 | 5,508,735 |
| 17/09/26 | 3.61 | 3.68 | 3.53 | 3.58 | 2,731,474 |
| 16/09/26 | 3.57 | 3.61 | 3.52 | 3.55 | 2,225,500 |
| 15/09/26 | 3.74 | 3.75 | 3.535 | 3.56 | 3,687,116 |
| 14/09/26 | 3.76 | 3.84 | 3.73 | 3.75 | 3,129,176 |
| 11/09/26 | 3.83 | 3.85 | 3.73 | 3.75 | 2,467,935 |
| 10/09/26 | 3.90 | 3.90 | 3.76 | 3.79 | 3,208,222 |
| 09/09/26 | 4.155 | 4.36 | 3.92 | 3.94 | 5,187,313 |
|
|
||||
|
|
||||
|
|